Launch price: $32 a month, locked for as long as you stay.

Free tracked US shipping. 90-day money-back guarantee.

Get my patches

Science

How does berberine work? AMPK, the gut and cholesterol, explained

An energy sensor, a gut chemist and a cholesterol trick. What we know about how berberine acts, and how strong each piece of evidence is.

By Norrapharm Editorial. Updated November 17, 2026. 7-minute read.

Key takeaways

  • Berberine's best-studied mechanism is activating AMPK, the enzyme cells use to sense their energy status (shown in cells and animals in 2006).
  • Gut bacteria convert berberine to dihydroberberine, which animals absorb about five times better.
  • Berberine raises liver LDL-receptor levels by stabilising their mRNA, a route distinct from statins.
  • Most mechanism evidence comes from cells and animals; human outcome data are from oral trials.

Berberine’s best-studied mechanism is activating AMPK, an enzyme that acts as the cell’s energy sensor. It also acts in the gut, where bacteria transform it and bitter-taste receptors respond to it, and it raises liver LDL-receptor levels by stabilising their messenger RNA. Most of this comes from cell and animal studies; human outcome data come from oral trials.

What is AMPK, and why does it matter?

AMP-activated protein kinase (AMPK) is a sensor inside nearly every cell. When energy runs low, AMPK switches the cell toward taking up glucose and burning fat, and away from building fat and cholesterol. Exercise activates it; so does the diabetes drug metformin. That’s why an AMPK activator attracts so much research interest.

How does berberine activate AMPK?

In 2006, researchers showed berberine increased AMPK activity in fat and muscle cells and had metabolic effects in diabetic and insulin-resistant rodents.1 Later work suggests berberine does this indirectly, by mildly slowing mitochondrial respiration (complex I), so the cell “feels” lower energy and AMPK responds. This single line of research helped turn an old herbal remedy into one of the most-researched plant compounds of the century.

What does berberine do in the gut?

A lot, it seems, which is surprising for a molecule that’s barely absorbed. In rats, under 1% of a swallowed dose reaches the bloodstream, while the liver sees around 70 times more than plasma.5 Three gut stories stand out:

  • Bacterial chemistry. Gut bacteria convert berberine to dihydroberberine, absorbed about five times better in animals, which then turns back into berberine.3
  • Bitter receptors. In human gut-lining cells, berberine triggered GLP-1 release through the bitter-taste receptor TAS2R38.4
  • The microbiome. Trials report shifts in gut-bacteria composition with oral berberine, though which changes matter is unclear.

How might berberine affect cholesterol?

A 2004 Nature Medicine paper found berberine raised LDL-receptor levels in human liver cells by stabilising the receptor’s mRNA, a mechanism distinct from statins.2 More receptors means more LDL cleared from the blood. In people, an 18-trial meta-analysis found modest LDL reductions with oral berberine.8

Is berberine a GLP-1 agonist?

No. GLP-1 agonists directly activate GLP-1 receptors and produce large clinical effects. Berberine’s GLP-1 connection is an indirect, gut-surface effect seen in cells. See Berberine and weight loss.

Which mechanisms are proven in humans, and which only in the lab?

Mechanism Main evidence Human relevance
AMPK activation Cells, rodents1 Plausible; not directly measured in most trials
LDL-receptor mRNA stabilisation Human liver cells, hamsters, small human series2 Supported by modest LDL drops in trials8
Gut conversion to dihydroberberine Animals3 Likely relevant to oral use
GLP-1 release via bitter receptors Human cell line4 Unknown in people
GDF15 from brown fat Mice6 Unknown in people
Healthy lifespan Worms7 Unknown in people

What would a patch need to do to matter?

Reach the body first. Most of the mechanisms above depend on berberine reaching cells in meaningful amounts, and several depend on the gut, which a skin patch bypasses. No human study has measured berberine in the blood after a patch; we cover that in Do berberine patches work?.

At Norrapharm, that’s exactly why we tell the science as science, in our research library, and sell The Berberine Patch as a daily ritual rather than a mechanism in a box. For the basics, start with What is berberine?; for absorption-boosting forms, see Dihydroberberine vs berberine.

Frequently asked questions

What is AMPK?

AMP-activated protein kinase is an enzyme found in nearly every cell. It senses when energy is running low and switches cells toward burning fuel and away from storing it. Exercise and the drug metformin also activate AMPK.

Is berberine a GLP-1 agonist?

No. A GLP-1 agonist directly activates GLP-1 receptors. Berberine triggered GLP-1 release from human gut cells in a lab study, via a bitter-taste receptor, which is a different and much weaker kind of effect.

Why is berberine so bitter?

Berberine activates bitter-taste receptors. Its early name, xanthopicrite, means 'yellow-bitter'. Researchers have since found bitter receptors on gut cells too, which may be part of how oral berberine acts.

Does berberine work the same way as metformin?

There's overlap: both activate AMPK, partly by affecting mitochondria. But they're different molecules with different evidence bases; metformin is an approved drug with decades of outcome data.

Norrapharm Editorial. Norrapharm makes berberine skin patches. This guide is written by our editorial team under our editorial standards. We don’t claim our patch causes weight loss or treats any condition.

Sources

  1. Lee YS et al. Berberine activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes. 2006;55(8):2256–64. pubmed.ncbi.nlm.nih.gov/16873688/
  2. Kong W et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med. 2004. pubmed.ncbi.nlm.nih.gov/15531889/
  3. Feng R et al. Transforming berberine into its intestine-absorbable form by the gut microbiota. 2015. pubmed.ncbi.nlm.nih.gov/26174047/
  4. Yu Y et al. Berberine induces GLP-1 secretion through TAS2R38 in human enteroendocrine cells. 2015. pubmed.ncbi.nlm.nih.gov/26206195/
  5. Liu YT et al. Low oral bioavailability; ~70× liver vs plasma exposure in rats. 2010. pubmed.ncbi.nlm.nih.gov/20634337/
  6. Li et al. Berberine raises GDF15 from brown fat in obese mice. 2023. pubmed.ncbi.nlm.nih.gov/36825874/
  7. Xiao et al. Berberine extends healthy lifespan in C. elegans via PMK-1/SKN-1. 2025. pubmed.ncbi.nlm.nih.gov/39357500/
  8. Blais JE et al. Berberine and lipids: meta-analysis of 18 placebo-controlled trials. 2023. pubmed.ncbi.nlm.nih.gov/36941490/

Keep reading